IP Library › Granted Patent US 8,864,844
Granted Patent B2
US 8,864,844 · App. 11/890,989 · Granted Oct 21, 2014

Tissue scaffold

Inventors: Anthony Ratcliffe (Del Mar, CA); Andreas Kern (San Diego, CA); Fatemeh Ratcliffe (Del Mar, CA)
Assignee: Synthasome, Inc.
A61L27/38A61L2300/406A61L27/3633A61L2300/414A61L2300/602A61L27/54A61L27/58
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,864,844
App. No.
11/890,989
Granted
Oct 21, 2014
Kind
B2
Abstract

A tissue engineered construct made totally or in part from biocompatible materials and mammalian cells and/or cell products is provided. These constructs are useful in regenerating complex tissues such as bone, ligament and tendon, which may fabricated into medical devices suitable for use in the treatment of injuries and maladies such as rotator cuff injuries, periodontal disease and hernia.

Claims (20)

1. A three-dimensional tissue comprising a biocompatible scaffold, a continuous membrane of bioabsorbable material encasing the scaffold, and extracellular matrix deposited directly by cells onto the scaffold, wherein the three-dimensional tissue comprises no living cells, wherein the bioabsorbable material is selected from at least one member of the group consisting of glycolide, lactide, trimethylene carbonate, dioxanone, caprolactone, alkylene oxides, ortho esters, polymers and copolymers therof, collagen, hyaluronic acids, alginates, and mixtures thereof.

2. A tissue according to claim 1 , further comprising at least one therapeutic agent.

3. A tissue according to claim 2 , wherein the therapeutic agent is selected from the group consisting of growth factors, cytokines, lipids, guidance factors, antimicrobial agents, and antibiotics.

4. A tissue according to claim 2 , wherein the therapeutic agent is VEGF or FGF4.

5. A tissue scaffold system comprising a biocompatible scaffold and a pre-formed, continuous biocompatible membrane comprising a synthetic polymer, the biocompatible membrane having an engineered surface texture, and wherein the tissue scaffold system comprises no living cells and the synthetic polymer comprises a bioabsorbable material selected from at least one member of the group consisting of glycolide, lactide, trimethylene carbonate, dioxanone, caprolactone, alkylene oxides, ortho esters, polymers and copolymers thereof, collagen, hyaluronic acids, alginates, and mixtures thereof.

6. A tissue scaffold system according to claim 5 , wherein the biocompatible scaffold comprises a three dimensional network.

7. A tissue scaffold system according to claim 6 , wherein the three dimensional network comprises a mesh.

8. A tissue scaffold system according to claim 6 , wherein the three dimensional network comprises a member selected from the group consisting of a non-woven felt and a sponge.

9. A tissue scaffold system according to claim 5 , wherein the biocompatible membrane includes a surface having ridges.

10. A tissue scaffold system according to claim 5 , wherein the biocompatible membrane includes a surface having grids.

11. A tissue scaffold system according to claim 5 , wherein the biocompatible membrane includes a surface having an ionic charge.

12. A tissue scaffold system according to claim 5 , wherein the biocompatible membrane includes a surface having a cell attachment ligand.

13. A tissue scaffold system according to claim 5 , wherein the biocompatible scaffold comprises a bioabsorbable material.

14. A tissue scaffold system according to claim 5 , wherein the biocompatible scaffold comprises a non-bioabsorbable material.

15. A tissue scaffold system according to claim 14 , wherein the non-bioabsorbable material is selected from at least one member of the group consisting of polypropylene, polyethylene, polyamide, polyalkylene therephalate, polyvinylidene fluoride, polytetraflouroethylene and blends and copolymers thereof.

16. A tissue scaffold system according to claim 5 , wherein the biocompatible membrane is bioabsorbable.

17. A tissue scaffold system according to claim 5 , wherein the scaffold is embedded in the biocompatible membrane.

18. A tissue scaffold system according to claim 5 , wherein the scaffold is enveloped by the biocompatible membrane.

19. A tissue scaffold system according to claim 5 , wherein the biocompatible membrane is layered with the scaffold.

20. A tissue scaffold system according to claim 5 , wherein the biocompatible membrane encases the biocompatible scaffold.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 19, 2014
From: RATCLIFFE, ANTHONY; KERN, ANDREAS; RATCLIFFE, FATEMEH
To: SYNTHASOME, INC.
Reel/Frame 033780/0428 →
Continuity (3)
Continuation PCTUS2005016393 · May 11, 2005
Provisional Application 60570204 · May 11, 2004
Related Publication 20070276509A1 · Nov 29, 2007